Cobimetinib fumarate is a fumarate salt of cobimetinib, formulated by combining two molecules of cobimetinib with one molecule of fumaric acid. It functions as an inhibitor of mitogen-activated protein kinase (MEK) and is utilized as an antineoplastic agent in combination therapy for certain cancers.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Cobimetinib Fumarate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Amrubicin
pharmaceutical raw material
(2S,3Z)-5-{[(2R,3R,5S,6S)-2,5-dimethyl-6-{(2E,4E)-3-methyl-5-[(3R,4R,5R,7S,8R)-4,7,8-trihydroxy-7-methyl-1,6-dioxaspiro[2.5]oct-5-yl]penta-2,4-dien-1-yl}tetrahydro-2H-pyran-3-yl]amino}-5-oxopent-3-en-2-yl acetate
pharmaceutical raw material
Chimmitecan
pharmaceutical raw material
Pomalidomide
pharmaceutical raw material
Lemborexant
pharmaceutical raw material
Sacubitril calcium
pharmaceutical raw material
Pralidoxime chloride, (Z)-
pharmaceutical raw material
Lotilaner
pharmaceutical raw material
(E)-but-2-enedioic acid;bis([3,4-difluoro-2-(2-fluoro-4-iodoanilino)phenyl]-[3-hydroxy-3-[(2S)-piperidin-2-yl]azetidin-1-yl]methanone)
RESIMIUSNACMNW-BXRWSSRYSA-N
C1CCN[C@@H](C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O.C1CCN[C@@H](C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O.C(=C/C(=O)O)\C(=O)O
Sourcing Cobimetinib Fumarate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.